Hsv 1 and 2 Gowey Protocol Versus Placebo

Naturopaths International

Status and phase: Completed; Phase 2; Phase 1

Conditions: Herpes

Treatments: Other: placebo (versabase gel only); Other: Versabase gel with sarracenia purpurea 20% liquid extract

Study type: Interventional

Funder types: Other

Identifiers

NCT01477879

HSV1&2

Details and patient eligibility

About

This study will compare efficacy of versabase gel with 20% sarracenia purpurea versus placebo applied every 3-4 hours to herpes lesions.

Full description

Patients screened for hsv one or two. Patients with herpes given a 1/8 oz of gel. Researcher does not know which is active and which is placebo (placebo is actually just versabase gel). Patent applies gel to lesions every 3-4 hours. Returns to clinic on days 3, 5, and 14 for evaluation. Up to 50 patients may be enrolled.

Enrollment: 33 patients

Sex: All

Ages: 18+ years old

Volunteers: Accepts Healthy Volunteers

Inclusion criteria

• Hsv 1&2

Exclusion criteria

• No active lesions

Trial design

Primary purpose: Treatment

Allocation: Randomized

Interventional model: Single Group Assignment

Masking: Quadruple Blind

---

33 participants in 2 patient groups, including a placebo group

Versabase/20% S. purpurea extract

Active Comparator group

Treatment:

Other: Versabase gel with sarracenia purpurea 20% liquid extract

placebo (versabase gel only)

Placebo Comparator group

Description:

placebo used will be versabase gel alone

Treatment:

Other: placebo (versabase gel only)